These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 14912809)

  • 21. THE CHANGING ROLE OF THE OTOLARYNGOLOGIST IN TUBERCULOSIS: EVALUATION OF ANTIBIOTICS IN HEARING IMPAIRMENT.
    CHEW W
    J Fla Med Assoc; 1964 Apr; 51():230-2. PubMed ID: 14139530
    [No Abstract]   [Full Text] [Related]  

  • 22. [In vitro effect of various substances on Mycobacterium tuberculosis. I. Titration of streptomycin, aureomycin, PAS, caffeic acid, 5-nitro-2-furaldehyde-semicarbazone and salicylic acid in Dubos medium].
    TERNI M; ZANELLI QUARANTINI MG
    Boll Ist Sieroter Milan; 1951; 30(11-12):689-702. PubMed ID: 14934836
    [No Abstract]   [Full Text] [Related]  

  • 23. [THE TREATMENT OF TUBERCULOSIS WITH 2ND LINE DRUGS].
    SCHWARTZ WS
    Sem Med; 1964 Mar; 124():523-34. PubMed ID: 14156390
    [No Abstract]   [Full Text] [Related]  

  • 24. [Contribution to the study of the sensitivity of "Bacterium pyocyaneum" to various antibiotics (polymyxin, neomycin, vancomycin, viomycin, ristocetin, kanamycin, colistine, streptomycin)].
    CARAFA V; FILADORO F; R ENZINI G
    Gazz Med Ital; 1961 Sep; 120():321-8. PubMed ID: 13876421
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effective tuberculostatic minimal concentration of streptomycin, conteben, PAS and neoteben in vitro and resistance phenomenon].
    WEIDMANN S; SAAME H
    Z Hyg Infektionskr; 1953; 136(6):579-86. PubMed ID: 13103314
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effect of combined treatment with streptomycin, PAS and isoniazid on resistance of Mycobacterium tuberculosis to streptomycin and isoniazid].
    JANKOV M
    Hig Cas Hig Mikrobiol Epidemiol Sanit Teh; 1955; 7(1-4):228-34. PubMed ID: 13405406
    [No Abstract]   [Full Text] [Related]  

  • 27. CAPREOMYCIN SUSCEPTIBILITY OF STRAINS RESISTANT TO STREPTOMYCIN AND/OR VIOMYCIN.
    VERBIST L; GYSELEN A
    Am Rev Respir Dis; 1964 Oct; 90():640-1. PubMed ID: 14221679
    [No Abstract]   [Full Text] [Related]  

  • 28. The effect of para-aminosalicylic acid (PAS) on the development of resistance of tubercle bacilli to streptomycin.
    FRIEDMAN B; SALE L; GOLDMAN A
    Am J Med Sci; 1952 Jul; 224(1):53-6. PubMed ID: 14933413
    [No Abstract]   [Full Text] [Related]  

  • 29. [Koch bacillus resistance to antibiotics in the inoculated and antibiotic-treated guinea pig].
    LE MELLETIER J; BROWAEYS J; CAULET T
    Ann Biol Clin (Paris); 1955; 13(5-6):305-8. PubMed ID: 13249138
    [No Abstract]   [Full Text] [Related]  

  • 30. A quantitative analysis of the resistance of Mycobacterium tuberculosis to streptomycin, isoniazid and PAS.
    TSUKAMURA M; NODA Y; MIURA K
    Kekkaku; 1956 Feb; 31(2):107-10. PubMed ID: 13320628
    [No Abstract]   [Full Text] [Related]  

  • 31. [ACTION OF CAPREOMYCIN ON MYCOBACTERIUM TUBERCULOSIS IN FLUID CULTURE MEDIA ALONE OR ASSOCIATED WITH STREPTOMYCIN, INH AND PAS].
    COLETSOS PJ; ORIOT E
    Ann Inst Pasteur (Paris); 1964 Aug; 107():215-31. PubMed ID: 14196629
    [No Abstract]   [Full Text] [Related]  

  • 32. [Streptomycin and PAS resistance of tubercle bacteria isolated from patients with tuberculous meningitis].
    VAN ZEBEN W; VAN GENDEREN H; MANTEN A
    Maandschr Kindergeneeskd; 1952 Apr; 20(3):69-83. PubMed ID: 14940043
    [No Abstract]   [Full Text] [Related]  

  • 33. [STUDIES ON DIFFERENCES IN EXPRESSION OF THE IN VITRO ACTIVITY OF ANTITUBERCULAR AGENTS IN VARIOUS COLONY-COUNTABLE MEDIA. 1. DIFFERENCES IN THE ANTIBACTERIAL STRENGTH ON OGAWA'S 1-PERCENT MEDIUM, KIRCHNER'S AGAR SLANT, AND KIRCHNER'S SEMISOLID AGAR].
    KAKU R
    Kekkaku; 1963 Nov; 38():517-23. PubMed ID: 14134127
    [No Abstract]   [Full Text] [Related]  

  • 34. [Fundamental experiments on combined effects of three anti-tuberculous agents, streptomycin, PAS and isoniazid. I. Studies mainly on the course of the resistance development of M. tuberculosis serially transferred in the cultural environment of three drugs used concomitantly].
    MIYAMOTO Y; UENO K
    Kekkaku; 1955 Nov; 30(11):659-63. PubMed ID: 13286850
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effects of streptomycin-resistance of Mycobacterium tuberculosis on induction rate of resistance to kanamycin, viomycin and capreomycin and on cross-resistance among these drugs].
    Nagata A; Mase M; Yamamoto M; Nakamura H
    Kekkaku; 1969 Jun; 44(6):173-9. PubMed ID: 4308767
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of combined therapy (dihydrostreptomycin and PAS) on the emergence of streptomycin-resistant strains of tubercle bacilli.
    SHANE SJ; LAURIE JH; RILEY C; BOUTILIER M
    N Engl J Med; 1952 Jan; 246(4):132-4. PubMed ID: 14890823
    [No Abstract]   [Full Text] [Related]  

  • 37. Studies on the drug resistance in mycobacteria with genetic reference; on the frequency of appearance of PAS-resistant mutants in Mycobacterium tuberculosis var. hominis simultaneously resistant to streptomycin and isoniazid.
    TSUKAMURA M
    J Antibiot (Tokyo); 1956 Sep; 9(5):186-90. PubMed ID: 13385196
    [No Abstract]   [Full Text] [Related]  

  • 38. [Practical viewpoints of resistance against streptomycin, PAS, conteben].
    UNHOLTZ K
    Tuberkulosearzt; 1952 Aug; 6(8):451-9. PubMed ID: 13005732
    [No Abstract]   [Full Text] [Related]  

  • 39. STUDIES ON CROSS-RESISTANCE BETWEEN CAPREOMYCIN AND CERTAIN OTHER ANTI-MYCOBACTERIAL AGENTS.
    KOSEKI Y; OKAMOTO S
    Jpn J Med Sci Biol; 1963 Feb; 16():31-8. PubMed ID: 14044251
    [No Abstract]   [Full Text] [Related]  

  • 40. [A new active antibiotic against Mycobacteria: viomycin].
    NITTI V
    Arch Tisiol Mal Appar Respir; 1951 Aug; 6(8):Varia, 299-304. PubMed ID: 14878565
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.